Gross Profit Margin Trend for Amgen

A Historical Perspective on Amgen's Financial Performance

Amgen Inc., a leading biotechnology company, has shown remarkable consistency in its gross profit margins over the years. From its early days in the mid-1980s, Amgen maintained a perfect 100% gross profit ratio, reflecting its strong market position and efficient cost management. However, as the company expanded and faced increased competition, its gross profit margin began to fluctuate.

In the late 1980s, Amgen's gross profit ratio started to show slight variations, dropping to around 99% by 1989. The early 1990s saw further adjustments, with the ratio stabilizing around 85% to 87%. This period of stability indicates Amgen's ability to adapt to market changes while maintaining a healthy profit margin.

The data reveals that Amgen's gross profit margin has generally remained robust, averaging around 86% over the years. This consistency underscores the company's strong financial health and its ability to generate substantial profits from its operations.

Key Insights

• 1985-1988: Amgen maintained a perfect 100% gross profit ratio.
• 1989: The ratio began to fluctuate, dropping to around 99%.
• 1990-1992: The gross profit margin stabilized around 85% to 87%.
• Overall: Amgen's average gross profit ratio over the years is approximately 86%.

Amgen's financial journey is a testament to its resilience and strategic prowess in the biotechnology sector. The company's ability to maintain a high gross profit margin over decades highlights its strong market position and operational efficiency.